DS
TAK icon

David Shaw’s Takeda Pharmaceutical TAK Stock Holding History

David Shaw’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.9M Sell
2,049,467
-553,076
-21% -$9.15M 0.02% 994
2026
Q1 		$48.2M Sell
2,602,543
-1,691,207
-39% -$29.7M 0.03% 677
2025
Q4 		$66.9M Buy
4,293,750
+4,012,456
+1,426% +$57.4M 0.04% 571
2025
Q3 		$4.12M Buy
+281,294
New +$4.18M ﹤0.01% 2382
2025
Q2 		– Sell
-56,036
Closed -$833K – 4708
2025
Q1 		$833K Buy
+56,036
New +$785K ﹤0.01% 3200
2024
Q4 		– Sell
-122,354
Closed -$1.74M – 4863
2024
Q3 		$1.74M Buy
+122,354
New +$1.74M ﹤0.01% 2808
2024
Q2 		– Sell
-354,299
Closed -$4.92M – 4830
2024
Q1 		$4.92M Buy
354,299
+139,342
+65% +$2.03M ﹤0.01% 1897
2023
Q4 		$3.07M Sell
214,957
-52,938
-20% -$751K ﹤0.01% 2321
2023
Q3 		$4.14M Sell
267,895
-19,224
-7% -$298K ﹤0.01% 1968
2023
Q2 		$4.51M Sell
287,119
-123,295
-30% -$2.02M ﹤0.01% 1925
2023
Q1 		$6.76M Buy
+410,414
New +$6.54M 0.01% 1690
2022
Q2 		– Sell
-237,726
Closed -$3.4M – 5766
2022
Q1 		$3.4M Buy
237,726
+47,415
+25% +$696K ﹤0.01% 2760
2021
Q4 		$2.59M Buy
+190,311
New +$2.67M ﹤0.01% 3112
2020
Q2 		– Sell
-200,080
Closed -$3.59M – 4248
2020
Q1 		$3.04M Sell
200,080
-340,536
-63% -$6.17M ﹤0.01% 1849
2019
Q4 		$10.7M Sell
540,616
-1,465,417
-73% -$28M 0.01% 1158
2019
Q3 		$34.5M Buy
2,006,033
+799,967
+66% +$13.8M 0.04% 526
2019
Q2 		$21.3M Buy
1,206,066
+886,083
+277% +$16.1M 0.03% 715
2019
Q1 		$6.52M Buy
+319,983
New +$6.44M 0.01% 1376

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

David Shaw's TAK Position: Q2 2026 in Review

David Shaw reduced its Takeda Pharmaceutical (TAK) stake by 21% in Q2 2026, selling an estimated $9.15M and leaving 2,049,467 shares worth $32.9M. The position accounts for 0.02% of the portfolio, ranked #994.

David Shaw first reported a position in TAK in Q1 2019 and has held it in 18 quarters since. The position peaked at $66.9M in Q4 2025. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • David Shaw held 2,049,467 shares of Takeda Pharmaceutical worth $32.9M as of Q2 2026.
  • David Shaw sold 553,076 Takeda Pharmaceutical shares in Q2 2026, an estimated $9.15M.
  • Takeda Pharmaceutical made up 0.02% of David Shaw's portfolio in Q2 2026, its #994 holding.
  • David Shaw first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 18 quarters since.
  • David Shaw's Takeda Pharmaceutical position peaked at $66.9M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.